Skip to main content

Table 2 Tumor response after GSMs-TACE treatment (n, %)

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

Post-operation

n

CR (%)

PR (%)

SD (%)

PD (%)

ORR (%)

DCR (%)

1 month

27

7 (25.93)

13 (48.15)

6 (22.22)

1 (3.70)

20 (74.07)

26 (96.30)